The framework is there: The U.S. Of ce of the Assistant Secretary for Health issued guidance authorizing licensed pharmacists to test for COVID-19 in April 2020, later clarifying that this authorization superseded state scopes of practice.

Rachel Balick

When a medication has caused harm, everyone involved with the distribution and use of that medication is potentially accountable for the harm, including any person who abused the medication resulting in that person’s death.

David B. Brushwood, BSPharm, JD

Medicaid managed care companies are working with the Ohio Department of Medicaid to act on a 2019 law that recognizes pharmacists as providers in Ohio.

Loren Bonner

Community pharmacists’ scope of practice is widening during COVID-19, with more patients seeking care from pharmacists and more pharmacies anticipating increased point-of-care testing and expanded immunization services.

Maria G. Tanzi, PharmD

Surprise! President Trump signed four executive orders aimed at lowering drug prices on Friday, July 24—and one of them includes a rebate reform rule long thought to be dead in the water.

Rachel Balick

Updates from FDA

Use of dexamethasone resulted in lower 28-day mortality among hospitalized patients with COVID-19, according to data from the RECOVERY trial published online in the New England Journal of Medicine.

Maria G. Tanzi, PharmD

The conventional wisdom used to be that high—and continuously rising—prices for insulin were the mandate of drug manufacturers.

Rachel Balick

More than 35 states have reported increases in opioid-related mortality since the COVID-19 crisis began, according to the American Medical Association.

Loren Bonner

Diaper dermatitis is an acute inflammation of the skin occurring in the region of the perineum, buttocks, lower abdomen, and inner thighs.

Daniel L. Krinsky, RPh, MS

On June 29, FDA approved Phesgo (Genentech) to treat adult patients with HER2-positive early stage and metastatic breast cancer.

Aina Abell

Stress and anxiety affect millions of people in the United States and have only worsened during the COVID-19 pandemic.

Aina Abell

Trending Topics in Health-System Pharmacy

New data suggest that the investigational antiviral drug remdesivir may interact with chloroquine phosphate or hydroxychloroquine sulfate and concurrent use of these agents is not recommended for the management of patients with COVID-19.

Maria G. Tanzi, PharmDMaria G. Tanzi, PharmD

May and June are typically transition months in the world of pharmacy education.

Joey Sweeney, PharmD, BCPS

To address drug shortages with neuromuscular blocking agents used in the management of critically ill patients with COVID-19, FDA has allowed vials of rocuronium and vecuronium to be temporarily manufactured without the usual vial cap warnings.

Maria G. Tanzi, PharmD

During the current pandemic, salicylate intoxication is unlikely to be at the top of many clinicians’ differential diagnosis list.

Joey Sweeney, PharmD, BCPS

Limited access to inclusive, affirming health care combined with exposure to stigmatizing and discriminatory experiences has resulted in multiple health disparities for lesbian, gay, bisexual, transgender and queer (LGBTQ) people.

Rhonda G. Schwindt, DNP, RN, PMHNP-BC

APhA Member News

Take the Crossword Challenge

“Thomas” was determined to do whatever it took to avoid having another heart attack.

Sonya Collins